It is important that consumers, educators, and regulators have a solid understanding of medical cannabis science. To this end, PSI is dedicated to presenting evidenced-based information to the general public, aspiring physicians, professionals, and government officials.
CBD Study: Accuracy in Labeling of CBD Products on the Market in Vermont 2017
In September 2017, PSI performed a pilot study that examined the potency of 24 CBD products available in Vermont and the accuracy of the dosage suggested on their product labels. Click here to see the poster.
The PSI team developed and currently teaches both the Cannabis Science and Medicine Professional Certificate Program and the medical cannabis course at the University of Vermont’s College of Medicine. This curriculum is the first of its kind to be offered by an accredited medical school in the United States and is designed for medical professionals, industry personnel, and budding scientists.
In 2016, PSI authored a white paper titled "Cannabis Testing for Public Safety – Best Practices for Vermont Analytical Laboratories” to aid the Vermont legislature in developing rules and regulations for ensuring the safety of the state’s medical Cannabis program.